Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
***
President Biden plans to end both the public health and national emergencies originally declared to address the Covid pandemic in 2020 (and extended several times since) on May 11th 2023.
The White House just disclosed the plan while opposing efforts by Republican lawmakers to end the emergency declarations immediately with a bill called the Pandemic Is Over Act. The end of the emergencies will mean that many Americans will have to start paying for COVID tests, treatments, and vaccines.
It also signals a shift in how serious the government considers the pandemic to be. But, is this wise?
***
***
COMMENTS APPRECIATED
Thank You
***
Share this:
Filed under: "Doctors Only", Breaking News, Drugs and Pharma, Ethics, Health Insurance, LifeStyle | Tagged: Biden, covid, covid pandemic, Official National Emergency Ending, pandemic, Pandemic Is Over Act |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Pocket Book
https://www.msn.com/en-us/health/other/factbox-what-ending-the-u-s-covid-health-emergency-means-for-your-pocket/ar-AA16XP8c?ocid=U521DHP&pc=U521&cvid=fe0af9e532c942ee8e752ac95065bcb5
Harry
LikeLiked by 1 person
When you develop life-saving treatments during a global pandemic, you’re going to end up making a lot of money.
Pfizer’s profits hit a record $100 billion last year—57% of which was accounted for by its Covid vaccine and the antiviral pill Paxlovid. In fact, the combined sales of the vaccine and Paxlovid in 2022 topped Pfizer’s total revenue in 2019. But with Covid not the health emergency it once was, Pfizer warned that demand for both products will crash this year.
Seal
LikeLiked by 1 person